| 英文别名 |
Astragaloside I;3-O-β-(2',3'-di-O-acetyl)-D-xylopyranosyl-6-O-β-D-glucopyranosyl-cycloastragenol;ASTRAGALOSIDE I(SH);ASTRAGALOSIDEⅠ;b-D-Glucopyranoside, (3b,6a,16b,20R,24S)-3-[(2,3-di-O-acetyl-b-D-xylopyranosyl)oxy]-20,24-epoxy-16,25-dihydroxy-9,19-cyclolanostan-6-yl;2,5-Bis[1-(1,1-dimethyl-2-propenyl)-1H-indol-3-yl]-3,6-dimethoxy-2,5-cyclohexadiene-1,4-dione;2,5-bis[1-(1,1-dimethylallyl)-1H-indol-3-yl]-3,6-dimethoxy-1,4-benzo;2,5-bis-[1-(1,1-dimethyl-allyl)-indol-3-yl]-3,6-dimethoxy-[1,4]benzoquinone;2,5-dimethoxy-3,6-bis[1-(2-methylbut-3-en-2-yl)-1H-indol-3-yl]cyclohexa-2,5-diene-1,4-dione;Asterrichinon-dimethylether;asterriquinone dimethyl ether;Astrasieversianin IV;Cyclosieversioside B;cyclosiversioside B;(3β,6α,16β,20R,24S)-3-[(2,3-Di-O-acetyl-β-D-xylopyranosyl)oxy]-20,24-epoxy-16,25-dihydroxy-9,19-cyclolanostan-6-yl β-D-glucopyranoside;AstragalosideI;Astragaloside-I;C43H68O16;X1090;ASTRAGALOSIDE cent inverted exclamation mark;680A751;3-O--(2\\',3\\'-di-O-acetyl)-D-xylopyranosyl-6-O--D-glucopyranosyl-cycloastragenol;[(2S,3R,4S,5R)-3-Acetyloxy-5-hydroxy-2-[[(1R,3R,6S,9S,11S,12S,14S,15R,16R)-14-hydroxy-15-[(2R,5S)-5-;CID 51346122;(3β,6α,16β,20R,24S)-3-[(2,3-Di-O-acetyl-β-D-xylopyranosyl)oxy]-20,24-epoxy-16,25-dihydroxy-9,19-cyclolanostan-6-yl β-D-glucopyranoside (ACI);1H,19H-Cyclopropa[9,10]cyclopenta[a]phenanthrene, β-D-glucopyranoside deriv. (ZCI);9,19-Cyclolanostane, β-D-glucopyranoside deriv. (ZCI);s9014;CS-3711;UNII-24CT26I88H;24CT26I88H;(3beta,6alpha,9beta,16beta,20R,24S)-3-[(2,3-di-O-acetyl-beta-D-xylopyranosyl)oxy]-16,25-dihydroxy-20,24-epoxy-9,19-cyclolanostan-6-yl beta-D-glucopyranoside;Astragaloside I (constituent of astragalus);beta-D-Glucopyranoside, (3beta,6alpha,16beta,20R,24S)-3-[(2,3-di-O-acetyl-beta-D-xylopyranosyl)oxy]-20,24-epoxy-16,25-dihydroxy-9,19-cyclolanostan-6-yl-;(3beta,6alpha,16beta,20R,24S)-3-[(2,3-Di-O-acetyl-beta-D-xylopyranosyl)oxy]-20,24-epoxy-16,25-dihydroxy-9,19-cyclolanostan-6-yl beta-D-glucopyranoside;(3beta,6alpha,9beta,16beta,20R,24S)-3-((2,3-di-O-acetyl-beta-D-xylopyranosyl)oxy)-16,25-dihydroxy-20,24-epoxy-9,19-cyclolanostan-6-yl beta-D-glucopyranoside;AKOS030526921;Q27163025;91739-00-3;beta-D-Glucopyranoside, (3beta,6alpha,16beta,20R,24S)-3-((2,3-di-O-acetyl-beta-D-xylopyranosyl)oxy)-20,24-epoxy-16,25-dihydroxy-9,19-cyclolanostan-6-yl;HY-N0432;AS-56628;Astragaloside I, >=97% (HPLC);[(2S,3R,4S,5R)-3-acetyloxy-5-hydroxy-2-[[(1S,3R,6S,8R,9S,11S,12S,14S,15R,16R)-14-hydroxy-15-[(2R,5S)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-7,7,12,16-tetramethyl-9-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl]oxy]oxan-4-yl] acetate;CHEBI:91024;ASTRAGALOSIDEI;Astragaloside I (constituent of astragalus) [DSC];C17797;Astragaloside I,98%;A-D-xylopyranosyl)oxy]-20,24-epoxy-16,25-dihydroxy-9,19-cyclolanostan-6-yl ;A,6;LS-15453;A,20R,24S)-... |
